Overview

Clinicians, researchers, and informed patients can use Perplexity to synthesize the latest clinical trial data and real-world studies comparing treatment approaches. Deep Research pulls from peer-reviewed journals, clinical trial registries, and treatment guidelines to present an evidence-based comparison with specific outcome numbers, not just general conclusions.

Your search

Specify the exact interventions, patient population, and outcome measures you want compared. Asking for specific data points and evidence quality signals that you want a clinical-grade synthesis, not a health blog summary.

What is the evidence on peer support interventions for chronic pain management, including outcomes on opioid reduction, quality of life, healthcare utilization, and which delivery models work best in primary care settings?

Perplexity's answer

Perplexity quantifies what's usually discussed in vague terms, pulling specific numbers from studies like the Cleveland Clinic M6 trial and the NYU Langone 50,000-patient analysis. Surgery patients lost 26.5% of body weight at two years versus 5.7% for GLP-1 patients in real-world practice. On diabetes remission, surgery achieves 50-59% at one year versus ~6-12% for GLP-1 RAs, with the response breaking out rates by procedure type and tracking how remission holds (or doesn't) at 5 and 7 years.

What makes this genuinely useful is the gap it highlights between trial results and real-world outcomes. Semaglutide achieves ~15% weight loss in trials but only 4.5% in practice. The response explains why: 50-70% first-year discontinuation rates driven by cost, side effects, and access. It also surfaces an emerging combination strategy (GLP-1 RAs after surgery for weight regain) and frames the core tradeoff as one-time curative intervention versus chronic medication dependence.

Tips
  • Ask Perplexity to generate a comparison table with specific numbers (weight loss %, remission rates, MACE hazard ratios, follow-up duration) from recent meta-analyses

  • Follow up with "What are the cost-effectiveness comparisons?" to see the long-term economic case for each approach